Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids
Scientific Reports · 2024
DOI: 10.1038/s41598-024-60693-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Yaoqu Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of MRgFUS, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, No.6 Qinren Road, Foshan, 528000, Guangd…. Hauptthemen laut MEDLINE: Leiomyoma, Diffusion Magnetic Resonance Imaging, High-Intensity Focused Ultrasound Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of this study was to investigate the value of diffusion-weighted imaging (DWI) as a potential non-gadolinium alternative for promptly assessing the hyperacute outcome of magnetic resonance-guided focused ultrasound (MRgFUS) treatment for uterine fibroids. In this retrospective study we included 65 uterine fibroids from 44 women, who underwent axial DWI (b-value: 800 s/mm 2 ) and contrast-enhanced (CE) MR within 15 min post-ablation. Two blinded observers independently reviewed the DWI findings of ablated necrotic lesions and measured their volumes on DWI and CE images. The post-ablation DWI images revealed clear depiction of ablative necrotic lesions in all fibroids, which were classified into two types: the bull’s eye sign (type 1) and the bright patch sign (type 2). The inter-observer intraclass correlation coefficient for classifying DWI signal types was 0.804 ( p < 0.001). Volumetric analysis of ablated necrosis using DWI and CE T1-weighted imaging showed no significant variance, nor did the non-perfused volume ratios (all p > 0.05). Bland–Altman analysis revealed a mean difference of 2.38% and 1.71% in non-perfused volume ratios between DWI and CE, with 95% limits of agreement from − 19.06 to 23.82% and − 18.40 to 21.82%, respectively. The findings of this study support the potential of DWI as a viable non-gadolinium alternative for evaluating the hyperacute outcomes of MRgFUS ablation in uterine fibroids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of MRgFUS, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, No.6 Qinren Road, Foshan, 528000, Guangdong, China. doctorhyq@163.com.
- Center of MRgFUS, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, No.6 Qinren Road, Foshan, 528000, Guangdong, China.
- Chancheng High-Tech District Hospital of Foshan Hospital of Traditional Chinese Medicine, Foshan, 528000, Guangdong, China.
- Department of Gynecology, Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, 528000, Guangdong, China.
Zitieren
APA
Huang, Y., Zhou, S., Su, Y., Pang, Z., & Cai, S. (2024). Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids. Scientific Reports. https://doi.org/10.1038/s41598-024-60693-4
Vancouver
Huang Y, Zhou S, Su Y, Pang Z, Cai S. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids. Scientific Reports. 2024. doi:10.1038/s41598-024-60693-4
BibTeX
@article{Huang2024,
author = {Huang, Yaoqu and Zhou, Shouguo and Su, Yinghua and Pang, Zhuochao and Cai, Shihua},
title = {Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-60693-4}
}
EUVIMED